Keloid Treatment Study
Part of Skin clinical trials.
This trial tests a new way to treat keloids by injecting medicine directly into the scar. It may help people with thick, raised scars that don't go away on their own.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 60 years old.
- You must have a keloid (a raised, thick scar that grows beyond the original wound).
- You cannot be pregnant or breastfeeding.
- You cannot have a skin disease that might affect the treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether injecting a substance called polidocanol, with or without a steroid, can reduce the size and improve the appearance of keloids and hypertrophic scars. It may help people who have had these scars for up to one year.
This study looks at how keloid scars form by studying the skin cells. You may be able to join if you are at least 18 years old, have a keloid, and are already planning to have surgery to remove it.
This study tests an experimental injection (9MW3811) to help improve the appearance and feel of thick, raised scars that haven't improved on their own in at least 6 months. The treatment may reduce redness, firmness, and other signs of abnormal scarring.
This study tests whether adding a cold therapy treatment (cryotherapy) to standard steroid injections can improve keloids and hypertrophic scars. If you are already getting steroid shots for your scar, you may be able to join and get both treatments on different parts of one scar.
This trial tests whether injecting a medicine called bleomycin is better than a standard treatment for reducing keloids. It compares two common treatments to see which works best for patients like you.
This study looks at whether removing a keloid with surgery and then applying a radioactive substance (called 32P) can help treat it. The researchers will also watch how well the treatment works over time to see what affects the outcome.
Hear when a new Scar, Hypertrophic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.